Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Mesenchymal Stem Cells for Systemic Sclerosis
NCT00962923Phase 2Unknown
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Aug 2009
- Primary completion
- Dec 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MSV alogénicas in systemic sclerosis (SSc), sponsored by Nanjing Drum-Tower Hospital. Status: unknown.
02
Drugs
MSV alogénicas
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00962923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00962923.